| Supplier |
Ace Therapeutics |
| Product # |
NSC1213 |
| Pricing |
Inquiry
|
| Product Size |
100 µg
|
| Purity |
> 97 % as determined by SDS-PAGE
|
| Product Type |
Proteins
|
| Endotoxin |
< 1.0 EU per μg of the protein as determined by the LAL method
|
| Activity |
Measured in a cell proliferation assay using human umbilical vein endothelial cells (HUVEC).The ED50 for this effect is typically 3-12 ng/ml.
|
| Protein Construction |
A DNA sequence encoding the human / cynomolgus VEGF165 isoform (P15692-4) (Met1-Arg191) was expressed. Human and Cynomolgus VEGF165 sequences are identical.
|
| Accession# |
P15692-4
|
| Expressed Host |
Baculovirus-Insect Cells
|
| Species |
Human, Cynomolgus
|
| Predicted N Terminal |
Ala 27
|
| Molecule Mass |
The recombinant human / cynomolgus VEGF165 consists of 165 amino acids after removal of the signal peptide and predicts a molecular mass of 19.2 kDa. Due to different glycosylation, the apparent molecular mass of human VEGF165 is approximately 20 and 22 kDa in SDS-PAGE under reducing conditions, corresponding to the monomer.
|
| Formulation |
Lyophilized from sterile 100mM Glycine, 10mM NaCl, pH 7.0Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
|
| Shipping |
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
|
| Stability & Storage |
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
| Reconstitution |
A hardcopy of datasheet with reconstitution instructions is sent along with the products. Please refer to it for detailed information.
|